The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Reported Russian COVID vaccine disinformation 'reprehensible' - UK's Raab

Fri, 16th Oct 2020 07:59

LONDON, Oct 16 (Reuters) - British Foreign Secretary Dominic
Raab said on Friday a reported Russian disinformation campaign
to undermine COVID-19 vaccine trials was "reprehensible" at a
time when countries should be coming together.

"We know that Russia has a track record in this area," he
told Sky News when asked about a Times newspaper report that
there was a Russian campaign to undermine an Oxford University
vaccine trial.

"Anyone trying to basically sabotage the efforts of those
trying to develop a vaccine are deeply reprehensible, and it's
pretty unacceptable and unjustified in any circumstances."
(Reporting by Guy Faulconbridge and Paul Sandle; editing by
Michael Holden)

Related Shares

More News
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.